Cancer Minute


Note to Readers

Cancer Minute ceased publication Monday, August 13, 2012. For more cancer genetic and genomics news, please check out GenomeWeb's other coverage here.

Brainy Avastin

A new study shows the drug's effectiveness in treating glioblastoma, Roche says.

This Week in the Medical Journals

In the medical journals this week: VEGF therapy for patients with metastatic renal-cell carcinoma, and more.

The Cons of Chemotherapy

Chemotherapeutic agents can shut down tumor cells, but the damage they inflict may cause greater havoc later on, a researcher says.

This Week in the Journal of the National Cancer Institute

In the Journal of the National Cancer Institute this week: prediagnostic IgE levels and risk of glioma, and more.

Jay Bradner's All About the Epigenetics

Epigenetics is the key to cancer, says one researcher.

This Week in Cancer Discovery

In Cancer Discovery this week: compensatory potential of receptor tyrosine kinases in cancer growth, and more.

'Faster, Cheaper, Deeper'

Long-range PCR could be used to improve breast cancer mutation screening.

This Week in Cancer Cell

In Cancer Cell this week: endothelial CCR2 signaling induced by colon carcinoma cells, and more.

Turncoats

A new study further explains why some cancer patients become resistant to treatment.

This Week in BMC Cancer

In BMC Cancer this week: DNA repair and replication genes in lung cancer, a selectively cytotoxic fusion protein against mutated p53, and more.

Worth It?

A new institute aims to determine whether cancer drugs are delivering bang for the buck.

This Week in the Medical Journals

In the medical journals this week: ACP and MUTYH mutation in colorectal cancer, combination therapy for metastatic breast cancer, and more.